ABC00570ZK

Doultegravir Imp F(Tri cyclic impurity)

Dolutegravir Impurity F is a tri-cyclic compound arising from an aberrant cyclization event during the synthesis of Dolutegravir, featuring a fused pyrimidine-benzene-lactam core with an esterified carboxylic acid side chain. Its structure incorporates a 1,2,4-triazole ring linked to a substituted pyrimidine, distinguishing it from the parent drug's pyridone moiety. The compound exhibits a rigid, planar conformation due to conjugated aromatic systems and an amidic linkage. This impurity is a critical synthetic byproduct formed via intramolecular nucleophilic attack during lactam formation. It serves as an HPLC reference standard for quantifying process-related impurities in Dolutegravir APIs.

On Request
Molecular Formula C13H14N2O6
Molecular Weight 294.2600
CAS Number 1246616-73-8 โœ“ Verified
PubChem CID 66594300 โ†—
Purity N/A
Product Type API Impurity
Parent Drug Doultegravir
Lead Time On Request
IUPAC Name (3S,7R)-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxylic acid

๐Ÿ“ Synonyms

1246616-73-8 DS7HC3Z5YA (4R,12aS)-3,4,6,8,12,12a-Hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxylic acid (4R,12aS)-3,4,6,8,12,12a-Hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid RefChem:1050502 (4R,12aS)-7-Hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid (4R,12aS)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxylic acid Dolutegravir impurity F Dolutegravir Impurity 62 Dolutegravir Impurity N13

๐Ÿ”ฌ Chemical Identifiers

C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)O)O
InChI=1S/C13H14N2O6/c1-6-2-3-21-8-5-14-4-7(13(19)20)10(16)11(17)9(14)12(18)15(6)8/h4,6,8,17H,2-3,5H2,1H3,(H,19,20)/t6-,8+/m1/s1
KVXRWTBFPVMIGC-SVRRBLITSA-N

Related Products